Evaluation of the inhibitory effect of 2,5-Dimethyl-Celecoxib on tamoxifen-sensitive and -resistant human breast cancer cells (MCF-7). Clinical Medicine and Pharmacology, [S. l.], v. 3, n. 1, 2026. DOI: 10.70731/sh45n436. Disponível em: https://jandoopress.com/journal/cmp/article/view/215. Acesso em: 16 jun. 2026.